Articles with public access mandates - Claudia VenerLearn more
Not available anywhere: 1
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
R De Angelis, E Demuru, P Baili, X Troussard, A Katalinic, MDC Lopez, ...
The Lancet Oncology 25 (3), 293-307, 2024
Mandates: European Commission
Available somewhere: 10
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
L Botta, G Gatta, R Capocaccia, C Stiller, A Cañete, L Dal Maso, K Innos, ...
The Lancet Oncology 23 (12), 1525-1536, 2022
Mandates: National Institute of Health and Medical Research, France, Slovenian …
The psychological risks associated with the non-medical switch from biologics to biosimilars
D Mazzoni, C Vener, K Mazzocco, D Monzani, G Pravettoni
Frontiers in psychology 12, 605643, 2021
Mandates: Government of Italy
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
E Demuru, S Rossi, L Ventura, L Dal Maso, S Guzzinati, A Katalinic, ...
Frontiers in oncology 13, 1114701, 2023
Mandates: European Commission, AIRC Foundation for Cancer Research in Italy
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy
F Morabito, C Adornetto, P Monti, A Amaro, F Reggiani, M Colombo, ...
Frontiers in Oncology 13, 1198992, 2023
Mandates: AIRC Foundation for Cancer Research in Italy
Clear improvement in real-world chronic myeloid leukemia survival: a comparison with randomized controlled trials
C Vener, S Rossi, P Minicozzi, R Marcos-Gragera, HA Poirel, M Maynadié, ...
Frontiers in oncology 12, 892684, 2022
Mandates: Fondazione Cariplo, European Commission, Government of Italy
Late mortality, subsequent malignant neoplasms and hospitalisations in long-term survivors of adolescent and young adult hematological cancers
A Trama, C Vener, P Lasalvia, A Bernasconi, Ada Working Group
Frontiers in Oncology 12, 823115, 2022
Mandates: Government of Italy
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project
M Franchi, C Vener, D Garau, U Kirchmayer, M Di Martino, M Romero, ...
Therapeutic Advances in Hematology 12, 2040620721996488, 2021
Mandates: European Commission, Government of Italy
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical …
S Cavalieri, C Vener, M LeBlanc, L Lopez-Perez, G Fico, C Resteghini, ...
Frontiers in Oncology 13, 1048593, 2023
Mandates: European Commission
Quality of life in head and neck cancer survivors: the Big Data for Quality of Life study
M Moreira-Soares, E IF Fossen, K J. Taylor, S Singer, K Hurley, S Thomas, ...
medRxiv, 2024.02. 02.24302118, 2024
Mandates: National Institute for Health Research, UK, European Commission
708TiP BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment
S Cavalieri, C Vener, M LeBlanc, LL Perez, G Fico, C Resteghini, ...
Annals of Oncology 33, S866, 2022
Mandates: European Commission
Publication and funding information is determined automatically by a computer program